CHAMPIONS ONCOLOGY, INC.
For the period ended Aug 27, 2026. Filed Aug 28, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Aug 27, 2026 · Filed Aug 28, 2026
Contents
October 14, 2026
To the Stockholders of Champions Oncology, Inc.:
The Annual Meeting of Stockholders of Champions Oncology, Inc., a Delaware corporation (the “Company”), will be held at the Company’s headquarters, located at One University Plaza, Suite 307, Hackensack, New Jersey 07601, on Wednesday, October 14, 2026 at 9:00 a.m., Eastern time, for the following purposes:
| 1. | Elect the seven Board of Director nominees named in the accompanying Proxy Statement to the Board of Directors for the ensuing year and until his successor has been elected and qualified, or until his earlier death, resignation or removal; |
| 2. | Ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2027; |
| 3. | Approve a non-binding advisory resolution relating to the compensation of our named executive officers; |
| 4. | Approve a non-binding advisory vote on the frequency of holding stockholder advisory votes on executive compensation; |
| 5. | Approve the 2026 Equity Incentive Plan (the “Incentive Plan”); and |
| 6. | Transact such other business as may properly come before the meeting or any adjournments or postponements thereof. |
The Board of Directors has fixed August 21, 2026 as the Record Date for the determination of stockholders entitled to notice of, and to vote at, the meeting.
UNLESS YOU PROVIDE SPECIFIC INSTRUCTIONS AS TO HOW TO VOTE, BROKERS MAY NOT VOTE YOUR SHARES OF COMMON STOCK ON THE ELECTION OF DIRECTORS OR THE NON-BINDING ADVISORY RESOLUTIONS RELATING TO THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on October 14, 2026
Pursuant to rules and regulations adopted by the Securities and Exchange Commission (the "SEC"), we have elected to provide access to our proxy materials over the Internet, allowing us to provide the information stockholders need, while lowering delivery and printing expenses. On or about August 31, 2026, we will mail to our stockholders a notice containing instructions on how our stockholders may access online our 2026 Proxy Statement and 2026 Annual Report on Form 10-K. Our Form 10-K does not constitute a part of the proxy solicitation material, but provides you with additional information about the Company. These materials are available on the following website: https://www.iproxydirect.com/CSBR.
We invite your attention to each of these documents, and we invite you to attend the Annual Meeting of Stockholders, in person.
By Order of the Board of Directors
/s/ Robert Brainin
Robert Brainin
Chief Executive Officer
Hackensack, New Jersey
August 28, 2026
EVEN IF YOU PLAN TO ATTEND THE MEETING IN PERSON, PLEASE VOTE YOUR SHARES ONLINE, OR UPON REQUEST, OBTAIN A PROXY CARD AND RETURN IT PROMPTLY TO OUR TABULATOR. IF YOU ATTEND THE MEETING IN PERSON, YOU MAY REVOKE YOUR PROXY AND VOTE IN PERSON AT THE MEETING.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.